TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8681
+0.0502 (6.14%)
At close: Feb 27, 2026, 4:00 PM EST
0.8256
-0.0425 (-4.90%)
After-hours: Feb 27, 2026, 5:25 PM EST

TELA Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
39119162220186217
Market Cap Growth
-61.51%-26.63%-26.42%18.68%-14.47%46.96%
Enterprise Value
53145146207163166
Last Close Price
0.873.026.6211.5012.8015.04
PS Ratio
0.501.722.775.326.3011.92
PB Ratio
22.494.188.5915.409.244.43
P/TBV Ratio
375.314.459.6718.6610.434.68
EV/Sales Ratio
0.682.092.495.015.549.13
Debt / Equity Ratio
27.991.512.272.811.570.63
Net Debt / Equity Ratio
8.90-0.34-0.21-0.12-0.62-0.89
Net Debt / EBITDA Ratio
-0.400.240.090.050.431.76
Net Debt / FCF Ratio
-0.440.230.100.040.401.77
Asset Turnover
1.350.840.800.640.400.24
Inventory Turnover
1.981.731.441.401.791.57
Quick Ratio
2.414.023.333.924.5611.67
Current Ratio
3.305.014.235.045.5812.60
Return on Equity (ROE)
--159.87%-281.23%-257.51%-96.28%-72.00%
Return on Assets (ROA)
-38.68%-31.66%-37.76%-37.39%-24.71%-20.46%
Return on Capital Employed (ROCE)
-79.50%-58.70%-72.20%-70.30%-56.70%-31.70%
Earnings Yield
-100.88%-31.81%-28.78%-20.10%-17.92%-13.26%
FCF Yield
-81.49%-35.80%-25.58%-18.89%-16.73%-11.34%
Buyback Yield / Dilution
-78.98%-24.74%-40.58%-12.40%-11.90%-632.24%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q